- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Industry News: Barco strikes a new profile
Having completed the sale of its 3D visualization unit to Toshiba Medical earlier this year, Barco projected a new , more concentrated look at ECR 2009.
Having completed the sale of its 3D visualization unit to Toshiba Medical earlier this year, Barco projected a new , more concentrated look at ECR 2009. The company is focusing attention on its latest innovation, a color workstation configured as two bezel-free 3-MP displays or one large screen 6-MP display. Also in the spotlight is the company’s new line of displays for hospital wide viewing of clinical data and images, as well as mammography and surgical displays, and calibration, quality assurance, and asset management tools.
This is the first outing for Barco since selling its advanced visualization group to Toshiba. The deal was done Feb. 3, bringing inhouse the development of 3D volume rendering and advanced visualization capabilities for all Toshiba imaging modalities. The Advanced Visualization Imaging System division (AVIS) began developing and selling medical 3D in 1991 as Voxar, a Scottish firm that was later purchased by Barco. For the past decade, Toshiba has used Voxar 3D visualization core software in its medical imaging products.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
ECR Study Examines Key Predictive Factors for Metastasis in Patients with High-Risk Prostate Cancer
February 28th 2024Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).
